BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 176 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2020. The put-call ratio across all filers is 0.12 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $145,960,000 | -7.1% | 1,231,000 | +8.0% | 3.04% | -8.8% |
| Q4 2021 | $157,103,000 | +21.1% | 1,140,000 | +22.0% | 3.33% | +15.9% |
| Q3 2021 | $129,770,000 | +51.5% | 934,200 | +5.9% | 2.88% | +24.1% |
| Q2 2021 | $85,673,000 | +19.4% | 882,500 | -15.9% | 2.32% | +16.9% |
| Q1 2021 | $71,754,000 | -17.3% | 1,049,800 | +3.6% | 1.98% | -29.7% |
| Q4 2020 | $86,815,000 | +4.0% | 1,012,900 | -21.1% | 2.82% | -27.2% |
| Q3 2020 | $83,486,000 | +3.4% | 1,284,200 | +16.3% | 3.87% | -25.2% |
| Q2 2020 | $80,750,000 | +339.4% | 1,104,500 | +104.5% | 5.18% | +103.8% |
| Q1 2020 | $18,376,000 | – | 540,000 | – | 2.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 450,422 | $6,251,857 | 14.11% |
| Liontrust Investment Partners LLP | 134,659 | $7,478,961 | 0.13% |
| Birchview Capital, LP | 7,365 | $102 | 0.07% |
| FNY Investment Advisers, LLC | 250 | $3 | 0.00% |
| FNY Investment Advisers, LLC | 18 | $0 | 0.00% |
| FNY Investment Advisers, LLC | 56 | $0 | 0.00% |
| McElhenny Sheffield Capital Management, LLC | 31 | $430 | 0.00% |
| Blue Trust, Inc. | 65 | $10 | 0.00% |
| IFP Advisors, Inc | 1 | $1 | 0.00% |